Quality of life study for patients with neuroendocrine tumors getting internal radiation therapy
Part of Cancer clinical trials.
This study looks at how internal radiation therapy (RIV) affects quality of life in people with neuroendocrine tumors. It aims to understand how well patients tolerate this treatment and how it impacts daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are starting a treatment called RIV (internal radiation therapy) for a neuroendocrine tumor, and your doctor has approved this treatment.
- You have received information about the study and agreed to take part.
- You are not in prison or under a legal guardianship that takes away your freedom to choose.
- You can join this study even if you are getting RIV again after previous treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well patients with neuroendocrine tumors handle oral cancer pills and how those pills affect their quality of life. The goal is to improve support and education for people taking these medications at home.
This study follows people with advanced neuroendocrine tumors (NETs) that cannot be removed by surgery or have spread. Its goal is to see how long patients can live without having serious side effects from treatment, so doctors can better understand which treatments are worth the risks.
This study asks people with neuroendocrine tumors to report how they’re doing, including quality of life and quality of care. Your answers can help doctors and hospitals understand what support works best.
This study collects information about how you feel and how treatment is delivered while you receive radiotherapy using the RefleXion Medical radiotherapy system. It may help doctors improve care and better understand what affects quality of life during treatment.
This trial studies how well people do—especially their quality of life—after SBRT radiation for primary kidney cancer that can’t be removed with surgery. It may help doctors understand which patients benefit most and what side effects to expect.
This trial studies how patients feel during and after radiation therapy for anal cancer. It uses questionnaires to understand symptoms and well-being, helping doctors improve care.
Hear when a new Metastatic Neuroendocrine Tumour trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.